Hurdles in therapy with regulatory T cells

Science Translational Medicine

Volumn 7, Issue 304, 2015, Pages

  Trzonkowski, Piotr ^a   Bacchetta, Rosa ^b   Battaglia, Manuela ^c   Berglund, David ^d   Bohnenkamp, Hermann Richard ^e   Ten Brinke, Anja ^f,q   Bushell, Andrew ^g   Cools, Nathalie ^h   Geissler, Edward K ⁱ   Gregori, Silvia ^j   Van Ham, S Marieke ^f,q   Hilkens, Catharien ^k   Hutchinson, James A ⁱ   Lombardi, Giovanna ^l   Madrigal, J Alejandro ^m   Marek Trzonkowska, Natalia ^a   Martinez Caceres, Eva M ⁿ   Roncarolo, Maria Grazia ^b,j   Sanchez Ramon, Silvia ^o   Saudemont, Aurore ^m   Sawitzki, Birgit ^p   more..

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UPPSALA UNIVERSITY   (Sweden)

^e MILTENYI BIOTEC GMBH   (Germany)

^f CENTRAL LABORATORY   (Netherlands)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^j SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l GUY S HOSPITAL   (United Kingdom)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^o HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^p CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^q UNIVERSITY OF AMSTERDAM   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL POPULATION; CELL THERAPY; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; END STAGE RENAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SAFETY; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL DEPLETION; TREATMENT FAILURE; TREATMENT RESPONSE; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; ECONOMICS; IMMUNOLOGY; IMMUNOTHERAPY; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; HUMANS; IMMUNOTHERAPY; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

EID: 84941241918     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa7721     Document Type: Review

References (66)

1. R. K. Gershon, K. Kondo, Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18, 723-737 (1970).
2. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor -chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
3. J. L. Riley, C. H. June, B. R. Blazar, Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 30, 656-665 (2009).
4. A. K. Abbas, C. Benoist, J. A. Bluestone, D. J. Campbell, S. Ghosh, S. Hori, S. Jiang, V. K. Kuchroo, D. Mathis, M. G. Roncarolo, A. Rudensky, S. Sakaguchi, E. M. Shevach, D. A. Vignali, S. F. Ziegler, Regulatory T cells: Recommendations to simplify the nomenclature. Nat. Immunol. 14, 307-308 (2013).
5. N. Marek-Trzonkowska, M. Mysliwiec, A. Dobyszuk, M. Grabowska, I. Techmanska, J. Juscinska, M. A. Wujtewicz, P. Witkowski, W. Mlynarski, A. Balcerska, J. Mysliwska, P. Trzonkowski, Administration of CD4+CD25highCD127-regulatory T cells preserves -cell function in type 1 diabetes in children. Diabetes Care 35, 1817-1820 (2012).
6. N. Marek-Trzonkowska, M. Myliwec, J. Siebert, P. Trzonkowski, Clinical application of regulatory T cells in type 1 diabetes. Pediatr. Diabetes 14, 322-332 (2013).
7. N. Marek-Trzonkowska, M. Myliwiec, A. Dobyszuk, M. Grabowska, I. Derkowska, J. Juciska, R. Owczuk, A. Szadkowska, P. Witkowski, W. Mynarski, P. Jarosz-Chobot, A. Bossowski, J. Siebert, P. Trzonkowski, Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets-results of one year follow-up. Clin. Immunol. 153, 23-30 (2014).
8. J. A. Bluestone, T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs. Clin. Trials NCT01210664 (2011).
9. P. Trzonkowski, M. Bieniaszewska, J. Juciska, A. Dobyszuk, A. Krzystyniak, N. Marek, J. Myliwska, A. Hellmann, First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127 T regulatory cells. Clin. Immunol. 133, 22-26 (2009).
10. M. F. Martelli, M. Di Ianni, L. Ruggeri, F. Falzetti, A. Carotti, A. Terenzi, A. Pierini, M. S. Massei, L. Amico, E. Urbani, B. Del Papa, T. Zei, R. Iacucci Ostini, D. Cecchini, R. Tognellini, Y. Reisner, F. Aversa, B. Falini, A. Velardi, HLAhaploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood 124, 638-644 (2014).
11. C. G. Brunstein, J. S. Miller, Q. Cao, D. H. McKenna, K. L. Hippen, J. Curtsinger, T. Defor, B. L. Levine, C. H. June, P. Rubinstein, P. B. McGlave, B. R. Blazar, J. E. Wagner, Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety prof le and detection kinetics. Blood 117, 1061-1070 (2011).
12. M. Di Ianni, F. Falzetti, A. Carotti, A. Terenzi, F. Castellino, E. Bonifacio, B. Del Papa, T. Zei, R. I. Ostini, D. Cecchini, T. Aloisi, K. Perruccio, L. Ruggeri, C. Balucani, A. Pierini, P. Sportoletti, C. Aristei, B. Falini, Y. Reisner, A. Velardi, F. Aversa, M. F. Martelli, Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117, 3921-3928 (2011).
13. R. Bacchetta, B. Lucarelli, C. Sartirana, S. Gregori, M. T. Lupo Stanghellini, P. Miqueu, S. Tomiuk, M. Hernandez-Fuentes, M. E. Gianolini, R. Greco, M. Bernardi, E. Zappone, S. Rossini, U. Janssen, A. Ambrosi, M. Salomoni, J. Peccatori, F. Ciceri, M. G. Roncarolo, Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front. Immunol. 5, 16 (2014).
14. A. Theil, S. Tuve, U. Oelschlagel, A. Maiwald, D. Dohler, D. Osmann, A. Zenkel, C. Wilhelm, J. M. Middeke, N. Shayegi, K. Trautmann-Grill, M. von Bonin, U. Platzbecker, G. Ehninger, E. Bonifacio, M. Bornhauser, Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. Cytotherapy 17, 473-486 (2015).
15. E. K. Geissler, The ONE Study compares cell therapy products in organ transplantation: Introduction to a review series on suppressive monocyte-derived cells. Transp. Res. 1, 11 (2012).
16. P. Desreumaux, A. Foussat, M. Allez, L. Beaugerie, X. Hebuterne, Y. Bouhnik, M. Nachury, V. Brun, H. Bastian, N. Belmonte, M. Ticchioni, A. Duchange, P. Morel-Mandrino, V. Neveu, N. Clerget-Chossat, M. Forte, J. F. Colombel, Safety and ef cacy of antigen-specif c regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143, 1207-17. e1-2 (2012).
17. D. Berglund, M. Karlsson, A. R. Biglarnia, T. Lorant, G. Tufveson, O. Korsgren, B. Carlsson, Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials. Clin. Exp. Immunol. 173, 310-322 (2013).
18. C. Baecher-Allan, E. Wolf, D. A. Haf er, Functional analysis of highly def ned, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin. Immunol. 115, 10-18 (2005).
19. R. Hulspas, L. Villa-Komarof, E. Koksal, K. Etienne, P. Rogers, M. Tuttle, O. Korsgren, J. C. Sharpe, D. Berglund, Purif cation of regulatory T cells with the use of a fully enclosed high-speed microf uidic system. Cytotherapy 16, 1384-1389 (2014).
20. J. Neudorfer, B. Schmidt, K. M. Huster, F. Anderl, M. Schiemann, G. Holzapfel, T. Schmidt, L. Germeroth, H. Wagner, C. Peschel, D. H. Busch, H. Bernhard, Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor-and virus-derived antigens. J. Immunol. Methods 320, 119-131 (2007).
21. Anthony Nolan Institute, WP02-Isolation of clinical grade umbilical cord blood regulatory T cells to treat Graft versus Host Disease, www. t-control. info/the-project (last assessed 31 March 2015).
22. S. Gregori, D. Tomasoni, V. Pacciani, M. Scirpoli, M. Battaglia, C. F. Magnani, E. Hauben, M. G. Roncarolo, Dif erentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944 (2010).
23. N. H. Litjens, M. Huisman, M. van den Dorpel, M. G. Betjes, Impaired immune responses and antigen-specif c memory CD4+ T cells in hemodialysis patients. J. Am. Soc. Nephrol. 19, 1483-1490 (2008).
24. A. Petrelli, E. Tresoldi, B. G. Mfarrej, A. Paganelli, D. Spotti, R. Caldara, A. Secchi, M. Battaglia, Generation of donorspecif c T regulatory type 1 cells from patients on dialysis for cell therapy after kidney transplantation. Transplantation 99, 1582-1589 (2015).
25. Q. Tang, J. A. Bluestone, Regulatory T-cell therapy in transplantation: Moving to the clinic. Cold Spring Harb. Perspect. Med. 3, a015552 (2013).
26. A. Trenado, M. Sudres, Q. Tang, S. Maury, F. Charlotte, S. Gregoire, M. Bonyhadi, D. Klatzmann, B. L. Salomon, J. L. Cohen, Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/dif erentiation of pathogenic T cells. J. Immunol. 176, 1266-1273 (2006).
27. P. A. Taylor, A. Panoskaltsis-Mortari, J. M. Swedin, P. J. Lucas, R. E. Gress, B. L. Levine, C. H. June, J. S. Serody, B. R. Blazar, L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104, 3804-3812 (2004).
28. N. Marek, M. Bieniaszewska, A. Krzystyniak, J. Juciska, J. Myliwska, P. Witkowski, A. Hellmann, P. Trzonkowski, The time is crucial for ex vivo expansion of T regulatory cells for therapy. Cell Transplant. 20, 1747-1758 (2011).
29. K. Gob, A. Krzystyniak, N. Marek-Trzonkowska, R. Misawa, L. J. Wang, X. Wang, O. Cochet, M. Tibudan, P. Langa, J. M. Millis, P. Trzonkowski, P. Witkowski, Impact of culture medium on CD4+ CD25(high)CD127(lo/neg) Treg expansion for the purpose of clinical application. Int. Immunopharmacol. 16, 358-363 (2013).
30. P. Hof mann, R. Eder, L. A. Kunz-Schughart, R. Andreesen, M. Edinger, Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood 104, 895-903 (2004).
31. P. Trzonkowski, M. Szaryska, J. Myliwska, A. Myliwski, Ex vivo expansion of CD4+CD25+ T regulatory cells for immunosuppressive therapy. Cytometry A. 75, 175-188 (2009).
32. S. Landwehr-Kenzel, F. Issa, S. H. Luu, M. Schmuck, H. Lei, A. Zobel, A. Thiel, N. Babel, K. Wood, H. D. Volk, P. Reinke, Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecif c natural regulatory T cells. Am. J. Transplant. 14, 594-606 (2014).
33. A. L. Putnam, N. Saf nia, A. Medvec, M. Laszkowska, M. Wray, M. A. Mintz, E. Trotta, G. L. Szot, W. Liu, A. Lares, K. Lee, A. Laing, R. I. Lechler, J. L. Riley, J. A. Bluestone, G. Lombardi, Q. Tang, Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am. J. Transplant. 13, 3010-3020 (2013).
34. N. Marek, A. Krzystyniak, I. Ergenc, O. Cochet, R. Misawa, L. J. Wang, K. Gob, X. Wang, G. Kilimnik, M. Hara, S. Kizilel, P. Trzonkowski, J. M. Millis, P. Witkowski, Coating human pancreatic islets with CD4+CD25(high)CD127-regulatory T cells as a novel approach for the local immunoprotection. Ann. Surg. 254, 512-518, discussion 518-519 (2011).
35. A. Krzystyniak, K. Gob, P. Witkowski, P. Trzonkowski, Islet cell transplant and the incorporation of Tregs. Curr. Opin. Organ Transplant. 19, 610-615 (2014).
36. The European Parliament and the Council, Regulation (EC) No 1394/2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Of cial Journal of the European Union 324, 121-137 (2007).
37. European Commission, "Report from the Commission to the European Parliament and the Council in accordance with Article 25 of Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004," European Commission, Brussels, 28 March 2014 COM(2014) 188 f nal (2014).
38. M. Edinger, P. Hof mann, Regulatory T cells in stem cell transplantation: Strategies and f rst clinical experiences. Curr. Opin. Immunol. 23, 679-684 (2011).
39. M. G. Roncarolo, S. Gregori, R. Bacchetta, M. Battaglia, Tr1 cells and the counter-regulation of immunity: Natural mechanisms and therapeutic applications. Curr. Top. Microbiol. Immunol. 380, 39-68 (2014).
40. M. G. Roncarolo, M. Battaglia, Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7, 585-598 (2007).
41. C. G. Brunstein, B. R. Blazar, J. S. Miller, Q. Cao, K. L. Hippen, D. H. McKenna, J. Curtsinger, P. B. McGlave, J. E. Wagner, Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biol. Blood Marrow Transplant. 19, 1271-1273 (2013).
42. S. N. Nadig, J. Wieckiewicz, D. C. Wu, G. Warnecke, W. Zhang, S. Luo, A. Schiopu, D. P. Taggart, K. J. Wood, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 16, 809-813 (2010).
43. P. Sagoo, N. Ali, G. Garg, F. O. Nestle, R. I. Lechler, G. Lombardi, Human regulatory T cells with alloantigen specif city are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3, 83ra42 (2011).
44. A. Schoenbrunn, M. Frentsch, S. Kohler, J. Keye, H. Dooms, B. Moewes, J. Dong, C. Loddenkemper, J. Sieper, P. Wu, C. Romagnani, N. Matzmohr, A. Thiel, A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg. J. Immunol. 189, 5985-5994 (2012).
45. C. Scotta, M. Esposito, H. Fazekasova, G. Fanelli, F. C. Edozie, N. Ali, F. Xiao, M. Peakman, B. Afzali, P. Sagoo, R. I. Lechler, G. Lombardi, Dif erential ef ects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+CD25+FOXP3+ T regulatory cell subpopulations. Haematologica 98, 1291-1299 (2013).
46. B. Afzali, F. C. Edozie, H. Fazekasova, C. Scotta, P. J. Mitchell, J. B. Canavan, S. Y. Kordasti, P. S. Chana, R. Ellis, G. M. Lord, S. John, R. Hilton, R. I. Lechler, G. Lombardi, Comparison of regulatory T cells in hemodialysis patients and healthy controls: Implications for cell therapy in transplantation. Clin. J. Am. Soc. Nephrol. 8, 1396-1405 (2013).
47. A. Siepert, S. Ahrlich, K. Vogt, C. Appelt, K. Stanko, A. Kuhl, J. van den Brandt, H. M. Reichardt, H. Nizze, M. Lehmann, M. Tiedge, H. D. Volk, B. Sawitzki, P. Reinke, Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells. Am. J. Transplant. 12, 2384-2394 (2012).
48. X. Valencia, C. Yarboro, G. Illei, P. E. Lipsky, Def cient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178, 2579-2588 (2007).
49. M. Battaglia, M. G. Roncarolo, Immune intervention with T regulatory cells: Past lessons and future perspectives for type 1 diabetes. Semin. Immunol. 23, 182-194 (2011).
50. C. de Andres, C. Aristimuno, V. de Las Heras, M. L. Martinez-Gines, M. Bartolome, R. Arroyo, J. Navarro, S. Gimenez-Roldan, E. Fernandez-Cruz, S. Sanchez-Ramon, Interferon beta-1a therapy enhances CD4+ regulatory Tcell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 182, 204-211 (2007).
51. N. Gagliani, C. F. Magnani, S. Huber, M. E. Gianolini, M. Pala, P. Licona-Limon, B. Guo, D. R. Herbert, A. Bulfone, F. Trentini, C. Di Serio, R. Bacchetta, M. Andreani, L. Brockmann, S. Gregori, R. A. Flavell, M. G. Roncarolo, Coexpression of CD49b and LAG-3 identif es human and mouse T regulatory type 1 cells. Nat. Med. 19, 739-746 (2013).
52. U. Schliesser, M. Chopra, A. Beilhack, C. Appelt, S. Vogel, J. Schumann, I. Panov, K. Vogt, S. Schlickeiser, S. Olek, K. Wood, C. Brandt, H. D. Volk, B. Sawitzki, Generation of highly ef ective and stable murine alloreactive Tregs by combined anti-CD4 mAb, TGF-, and RA treatment. Eur. J. Immunol. 43, 3291-3305 (2013).
53. P. Trzonkowski, E. Szmit, J. Myliwska, A. Dobyszuk, A. Myliwski, CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cellto-cell interaction. Clin. Immunol. 112, 258-267 (2004).
54. S. N. Sherston, K. Vogt, S. Schlickeiser, B. Sawitzki, P. N. Harden, K. J. Wood, Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients. Am. J. Transplant. 14, 2617-2622 (2014).
55. J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, S. Olek, A. Hamann, H. von Boehmer, J. Huehn, DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654-1663 (2008).
56. M. Vukmanovic-Stejic, Y. Zhang, J. E. Cook, J. M. Fletcher, A. McQuaid, J. E. Masters, M. H. Rustin, L. S. Taams, P. C. Beverley, D. C. Macallan, A. N. Akbar, Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116, 2423-2433 (2006).
57. M. K. Rahman, C. P. Of ord, S. Khanna, G. C. Ford, X. M. Perrson, P. A. Svingen, Y. Xiong, Z. Bajzer, W. A. Faubion, Jr., Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease. Hum. Immunol. 74, 145-150 (2013).
58. A. J. Managh, R. W. Hutchinson, P. Riquelme, C. Broichhausen, A. K. Wege, U. Ritter, N. Ahrens, G. E. Koehl, L. Walter, C. Florian, H. J. Schlitt, H. J. Reid, E. K. Geissler, B. L. Sharp, J. A. Hutchinson, Laser ablation-inductively coupled plasma mass spectrometry: An emerging technology for detecting rare cells in tissue sections. J. Immunol. 193, 2600-2608 (2014).
59. A. J. Managh, S. L. Edwards, A. Bushell, K. J. Wood, E. K. Geissler, J. A. Hutchinson, R. W. Hutchinson, H. J. Reid, B. L. Sharp, Single cell tracking of gadolinium labeled CD4+ T cells by laser ablation inductively coupled plasma mass spectrometry. Anal. Chem. 85, 10627-10634 (2013).
60. E. Sharif-Paghaleh, K. Sunassee, R. Tavare, K. Ratnasothy, A. Koers, N. Ali, R. Alhabbab, P. J. Blower, R. I. Lechler, L. A. Smyth, G. E. Mullen, G. Lombardi, In vivo SPECT reporter gene imaging of regulatory T cells. PLOS ONE 6, e25857 (2011).
61. W. D. Docke, C. Hof ich, K. A. Davis, K. Rottgers, C. Meisel, P. Kiefer, S. U. Weber, M. Hedwig-Geissing, E. Kreuzfelder, P. Tschentscher, T. Nebe, A. Engel, G. Monneret, A. Spittler, K. Schmolke, P. Reinke, H. D. Volk, D. Kunz, Monitoring temporary immunodepression by f ow cytometric measurement of monocytic HLA-DR expression: A multicenter standardized study. Clin. Chem. 51, 2341-2347 (2005).
62. B. Sawitzki, C. Brunstein, C. Meisel, J. Schumann, K. Vogt, C. Appelt, J. M. Curtsinger, M. R. Verneris, J. S. Miller, J. E. Wagner, B. R. Blazar, Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression. Biol. Blood Marrow Transplant. 20, 173-182 (2014).
63. H. Waldmann, S. Cobbold, Regulating the immune response to transplants. a role for CD4+ regulatory cells Immunity 14, 399-406 (2001).
64. M. Streitz, T. Miloud, M. Kapinsky, M. R. Reed, R. Magari, E. K. Geissler, J. A. Hutchinson, K. Vogt, S. Schlickeiser, A. H. Kverneland, C. Meisel, H. D. Volk, B. Sawitzki, Standardization of whole blood immune phenotype monitoring for clinical trials: Panels and methods from the ONE study. Transp. Res. 2, 17 (2013).
65. N. Saf nia, T. Vaikunthanathan, H. Fraser, C. Scotta, R. Lechler, G. Lombardi, PTU-122 A GMP Tregs expansion protocol restores Treg suppressor function and in end-stage liver disease; Implications for adoptive transfer therapy. Gut 63 (suppl. 1), A92-A93 (2014).
66. U. Schulze, M. Ringel, What matters most in commercial success: First-in-class or best-in-class Nat. Rev. Drug Discov. 12, 419-420 (2013).